← Leaderboards
Aravind Asokan
Duke University
$26,081,479
Attributed
$31,128,708
Total exposure
13
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.2M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$33,434,532 · 14
By mechanism
R01$23,378,322 · 8
P01$4,031,421 · 3
UG3$2,129,209 · 1
UH3$1,992,277 · 1
U01$1,903,303 · 1
Top collaborators
- Andrew Serghios Barbas4 shared
- Allan D. Kirk4 shared
- Jonah B. Sacha4 shared
- Karl-Dimiter Bissig3 shared
- Matthew H Wilson1 shared
Most similar at Duke University
Same institution · by research overlap
- Stephan Zuchner$30,061,220
- Michael S Boyce$8,047,486
- Jen-Tsan Ashley Chi$7,491,502
- Andrew Serghios Barbas$3,383,335
Others in their field
Top investigators on “Adeno-Associated Viral Vector”
- Randall J Bateman · Washington University$63,044,576
- Jeffrey S Chamberlain · University Of Michigan At Ann Arbor$36,655,814
- Michael R. Farzan · Boston Children'S Hospital$33,579,607
- Mark A Kay · Stanford University$25,012,385
- Beverly L Davidson · University Of Iowa$19,750,165
- Ronald G Crystal · Weill Medical College Of Cornell Univ$17,607,629
Research focus
Adeno-Associated Viral VectorGene TherapyEngineeringCapsidDoseDesignVectorMediatingMapsIn VivoCellsMouse ModelLiverAnimalsSerotypingClinical TrialsLibrariesAnimal ModelVariantIn VitroDependovirusTissuesGene TransferCell Type
Grant awards (60)
Immunomodulation in AAV gene therapy$3,192,404
R01 · FY2025 · AI · contact PI
Evolving Novel AAV Vectors for Gene Therapy to Cure HIV$1,943,700
R01 · FY2025 · AI
Kidney targeted AAV for gene therapy$859,980
R01 · FY2025 · DK
Determinants of AAV Tropism$706,729
R01 · FY2025 · HL · contact PI
Dissecting AAV silencing in humanized mice$616,213
R01 · FY2025 · DK
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors$469,775
U01 · FY2025 · AI
Engineering the biology of AAV secretion and production$456,997
R01 · FY2025 · EB · contact PI
Evolving Novel AAV Vectors for Gene Therapy to Cure HIV$971,850
R01 · FY2024 · AI
Determinants of AAV Tropism$732,144
R01 · FY2024 · HL · contact PI
Dissecting AAV silencing in humanized mice$591,564
R01 · FY2024 · DK
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors$473,435
U01 · FY2024 · AI
Engineering the biology of AAV secretion and production$447,858
R01 · FY2024 · EB · contact PI
Evolving Novel AAV Vectors for Gene Therapy to Cure HIV$971,850
R01 · FY2023 · AI
Dissecting AAV silencing in humanized mice$616,213
R01 · FY2023 · DK
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors$477,093
U01 · FY2023 · AI
Engineering the biology of AAV secretion and production$456,997
R01 · FY2023 · EB · contact PI
Evolving High Potency AAV Vectors for Neuromuscular Genome Editing$1,158,674
UH3 · FY2022 · AR · contact PI
Evolving Novel AAV Vectors for Gene Therapy to Cure HIV$985,350
R01 · FY2022 · AI
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors$483,000
U01 · FY2022 · AI
Evolving High Potency AAV Vectors for Neuromuscular Genome Editing$833,603
UH3 · FY2021 · AR · contact PI
Determinants of AAV Tropism$628,152
R01 · FY2021 · HL · contact PI
RE-ENGINEERING AAV GENOME PACKAGING$486,413
R01 · FY2021 · GM · contact PI
CircRNAs and CNS Gene Transfer$375,678
R01 · FY2021 · NS · contact PI
Evolving High Potency AAV Vectors for Neuromuscular Genome Editing$663,989
UG3 · FY2020 · AR · contact PI
Determinants of AAV Tropism$628,152
R01 · FY2020 · HL · contact PI
RE-ENGINEERING AAV GENOME PACKAGING$486,413
R01 · FY2020 · GM · contact PI
CircRNAs and CNS Gene Transfer$375,753
R01 · FY2020 · NS · contact PI
Evolving High Potency AAV Vectors for Neuromuscular Genome Editing$719,081
UG3 · FY2019 · AR · contact PI
Determinants of AAV Tropism$628,152
R01 · FY2019 · HL · contact PI
RE-ENGINEERING AAV GENOME PACKAGING$494,348
R01 · FY2019 · GM · contact PI
CircRNAs and CNS Gene Transfer$378,326
R01 · FY2019 · NS · contact PI
Evolving High Potency AAV Vectors for Neuromuscular Genome Editing$746,139
UG3 · FY2018 · AR · contact PI
Determinants of AAV Tropism$622,381
R01 · FY2018 · HL · contact PI
RE-ENGINEERING AAV GENOME PACKAGING$494,232
R01 · FY2018 · GM · contact PI
CircRNAs and CNS Gene Transfer$351,161
R01 · FY2018 · NS · contact PI
CircRNAs and CNS Gene Transfer$33,636
R01 · FY2018 · NS · contact PI
Re-engineering AAV genome packaging$14,121
R01 · FY2018 · GM · contact PI
Determinants of AAV Tropism$448,381
R01 · FY2017 · HL · contact PI
CircRNAs and CNS Gene Transfer$398,672
R01 · FY2017 · NS · contact PI
HUMANIZING AAV VECTORS FOR GENE THERAPY$164,905
P01 · FY2017 · HL · contact PI
HUMANIZING AAV VECTORS FOR GENE THERAPY$164,903
P01 · FY2017 · HL · contact PI
Neutralizing Antibody & AAV FIX Gene Therapy$2,305,824
P01 · FY2016 · HL · contact PI
Determinants of AAV Tropism$456,099
R01 · FY2016 · HL · contact PI
HUMANIZING AAV VECTORS FOR GENE THERAPY$167,202
P01 · FY2016 · HL · contact PI
HUMANIZING AAV VECTORS FOR GENE THERAPY$167,200
P01 · FY2016 · HL · contact PI
Determinants of AAV Tropism$449,257
R01 · FY2015 · HL · contact PI
HUMANIZING AAV VECTORS FOR GENE THERAPY$164,729
P01 · FY2015 · HL · contact PI
HUMANIZING AAV VECTORS FOR GENE THERAPY$164,728
P01 · FY2015 · HL · contact PI
Determinants of AAV Tropism$8,418
R01 · FY2015 · HL · contact PI
Determinants of AAV Tropism$384,608
R01 · FY2014 · HL · contact PI
HUMANIZING AAV VECTORS FOR GENE THERAPY$163,767
P01 · FY2014 · HL · contact PI
HUMANIZING AAV VECTORS FOR GENE THERAPY$163,763
P01 · FY2014 · HL · contact PI
HUMANIZING AAV VECTORS FOR GENE THERAPY$404,400
P01 · FY2013 · HL · contact PI
Determinants of AAV Lung Tropism$278,974
R01 · FY2013 · HL · contact PI
Determinants of AAV Lung Tropism$293,040
R01 · FY2012 · HL · contact PI
Determinants of AAV Lung Tropism$296,000
R01 · FY2011 · HL · contact PI
Determinants of AAV Lung Tropism$296,000
R01 · FY2010 · HL · contact PI
Determinants of AAV Lung Tropism$295,417
R01 · FY2009 · HL · contact PI
Determinants of AAV Lung Tropism$219,040
R01 · FY2009 · HL · contact PI
Determinants of AAV Lung Tropism$7,649
R01 · FY2009 · HL · contact PI